| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
6e-11 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-09 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
5e-09 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-07 |
| mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
3e-07 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-07 |
| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
3e-07 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-07 |
| mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
8e-07 |